•
Finance
The Economics of Patient Finance: What Actually Drives Profitability

Chapter Four
Start with the right mental model
The biggest mistake practices make is simple:
comparing finance to card fees.
Cards: ~0.5%
Finance: ~6–10%
Conclusion:
“Finance is too expensive”
This is wrong.
Finance is not a payment method.
It is a conversion and growth system.
The real economic model
You don’t optimise finance per transaction.
You optimise it across the business.
Step 1: Define your target finance share
Decide upfront:
What % of treatments should use finance?
→ e.g. 30%, 50%, 70%
This is not theoretical.
SmileDirectClub: ~70%
Leading Invisalign providers: 40–60%
Step 2: Build finance into your margin
For a treatment:
Price: £X
Gross margin target: X%
Expected finance share: X%
Finance cost: X%
You then ensure:
your blended margin still works.
Step 3: Stop optimising cost per loan
Once unit economics are correct:
your goal is simple: maximise case volume.
What goes wrong in practice
Many groups try to “improve” finance by making it more attractive.
Real example: 24-month 0% rollout
A large group moved from:
12 months 0%
24 months 5.9%
To:
24 months 0%
Expected outcome
more finance usage
higher conversion
Actual outcome
no increase in usage
no increase in treatments
shift from 12 → 24 months
Result
higher cost, zero growth
Key insight: Finance adoption is driven by process—not product.
The role of APR (and why most get it wrong)
Most practices think:
patients want 0%
APR reduces conversion
Reality:
0% is preferred
but APR has limited impact on completion
What APR actually does
APR is a tool to:
control cost
shape behaviour
create trade-offs
The correct way to design finance options
This is where most practices fail.
Principle 1: Keep it simple
Do not offer:
6–8 options
or let staff choose freely
Instead:
define 3–4 standard options per treatment size
Principle 2: Use an APR ladder (not flat pricing)
APR should increase with term.
Example for £3,000 treatment)
Term | APR | Monthly | Practice Cost |
12 months | 0% | £250 | High |
24 months | ~5.9% | ~£132 | Similar / lower |
36–48 months | ~9.9% | £70–£75 | Lower |
Why this works
patients choose based on monthly affordability
practice avoids over-subsidising long terms
economics become predictable
Principle 3: Avoid large jumps
Bad structure:
12 months → 0%
36 months → 9.9%
Good structure:
gradual increase in APR
This allows:
smoother decision-making
better distribution across options
The myth of “lowest monthly wins”
A common instinct:
offer the lowest possible monthly payment
Why this fails
Lower monthly:
attracts more applicants
but lowers quality
Result:
more declines
weaker conversion
Real example
Smile White tested:
60-month low monthly option
Result:
lower-quality demand
worse conversion
Better strategy
Position slightly higher monthly:
attracts stronger applicants
improves approvals
increases completion
Key insight: The best customer is not the one who needs the lowest monthly payment.
The simplest winning setup
For most practices, this is sufficient:
For treatments £1,000–£4,000:
Offer:
12 months — 0% APR
24 months — ~5.9% APR
36–48 months — ~9.9% APR
Rules:
always offer all three
never customise per patient
let the patient choose
Optional optimisation
You can:
shorten 0% to 10 months → reduce fees by ~10–20%
replace 24-month 0% with 20-month ~5.9%
What actually drives profitability
It’s not:
lowering APR
or extending 0%
It’s:
1. Consistent usage
Finance must be:
offered every time
not selectively
2. Standardisation
same options
same structure
no decision fatigue
3. Volume
Once economics work: more cases = more profit
Final takeaway
The economics of patient finance are simple:
Don’t optimise for:
lowest cost per loan
Optimise for:
predictable margin
consistent usage
maximum case volume
Closing insight
Finance is not expensive when used correctly.
It is expensive when underused.
Transition
With economics defined, the next step is:
How to operationalise this into a consistent, scalable system across practices.